Afstyla (lonoctocog alfa) is an unknown pharmaceutical. Lonoctocog alfa was first approved as Afstyla on 2017-01-04. It is used to treat factor VII deficiency, hemophilia a, hemorrhage, and von willebrand diseases in the USA. It has been approved in Europe to treat hemophilia a.
|Common Name||Lonoctocog alfa|
|Indication||factor vii deficiency, hemophilia a, hemorrhage, von willebrand diseases|